Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Genetic and catalytic efficiency structure of an HCV protease quasispecies.
Clinical approach to drug resistance interpretation: expert advice.
Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.
Alternation of antiretroviral drug regimens for HIV infection. Efficacy, safety and tolerability at week 96 of the Swatch Study.
Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load.
New antiretroviral drugs and approaches to HIV treatment.
Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study.
Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine.
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.
Psychological impact of structured treatment interruptions in patients with prolonged undetectable HIV-1 viral loads.